UK markets closed
NIKKEI 225
27,883.78 +365.53 (+1.33%) HANG SENG
20,192.40 +407.75 (+2.06%) CRUDE OIL
72.85 -0.35 (-0.48%) GOLD FUTURES
1,967.30 -6.20 (-0.31%) DOW
32,666.28 +272.03 (+0.84%) Bitcoin GBP
23,017.03 +854.90 (+3.86%)
Emergent BioSolutions Inc. (0IGA.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:29PM BST
| Previous close | 8.84 |
| Open | 10.67 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 8.91 - 10.67 |
| 52-week range | 8.91 - 10.67 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 4.084M |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | 0.03 |
| EPS (TTM) | 2.97 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Emergent Biosolutions (EBS) Down 28.1% Since Last Earnings Report: Can It Rebound?
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Motley Fool
Why Emergent BioSolutions Stock Is Sinking Today
Shares of Emergent BioSolutions (NYSE: EBS) were sinking 12.8% lower as of 10:53 a.m. ET on Friday. Fye also slashed the 12-month price target for Emergent BioSolutions from $23 to $9. Emergent BioSolutions certainly faces some challenges, though, that could justify investors' caution.
- Simply Wall St.
Emergent BioSolutions Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Emergent BioSolutions ( NYSE:EBS ) Full Year 2022 Results Key Financial Results Revenue: US$1.12b (down 38% from FY...
© 2023 Yahoo. All rights reserved.
